However, the physiological consequences of modulating angiogenic activity seem to be context-dependent: gain of function studies show that overexpression of VEGF-A improves metabolic profiles, which maintains tissue function during the early phase of diet-induced obesity (44). The gene discussed is VEGFA; the disease is Obesity.